APUS News
Official issuer or fund updates, exact SEC current reports, and large established publisher coverage, newest first. Every lawfully retained item remains in the corpus; each public page contains at most 100 rows. Headlines open the exact source; summaries are concise descriptions and not investment recommendations. Captured 2026-08-31.
| Date | Type | Publisher | Headline | Summary |
|---|---|---|---|---|
| 2026-08-21 | Current report | SEC filing | Apimeds Pharmaceuticals US, Inc. filed Form 8-K | Apimeds Pharmaceuticals US, Inc. filed Form 8-K covering items 1.01,9.01. |
| 2026-08-06 | Current report | SEC filing | Apimeds Pharmaceuticals US, Inc. filed Form 8-K | Apimeds Pharmaceuticals US, Inc. filed Form 8-K covering items 8.01,9.01. |
| 2026-07-13 | Current report | SEC filing | Apimeds Pharmaceuticals US, Inc. filed Form 8-K | Apimeds Pharmaceuticals US, Inc. filed Form 8-K covering items 8.01,9.01. |
| 2026-05-05 | Current report | SEC filing | Apimeds Pharmaceuticals US, Inc. filed Form 8-K | Apimeds Pharmaceuticals US, Inc. filed Form 8-K covering items 5.02. |
| 2026-05-04 | Current report | SEC filing | Apimeds Pharmaceuticals US, Inc. filed Form 8-K | Apimeds Pharmaceuticals US, Inc. filed Form 8-K covering items 1.01,5.02,8.01,9.01. |
| 2026-04-22 | Current report | SEC filing | Apimeds Pharmaceuticals US, Inc. filed Form 8-K | Apimeds Pharmaceuticals US, Inc. filed Form 8-K covering items 3.01,9.01. |
| 2026-04-16 | Current report | SEC filing | Apimeds Pharmaceuticals US, Inc. filed Form 8-K | Apimeds Pharmaceuticals US, Inc. filed Form 8-K covering items 8.01. |
| 2026-04-09 | Current report | SEC filing | Apimeds Pharmaceuticals US, Inc. filed Form 8-K/A | Apimeds Pharmaceuticals US, Inc. filed Form 8-K/A covering items 5.02,5.03,8.01,9.01. |
| 2026-03-26 | Current report | SEC filing | Apimeds Pharmaceuticals US, Inc. filed Form 8-K | Apimeds Pharmaceuticals US, Inc. filed Form 8-K covering items 5.02,5.03,8.01,9.01. |
| 2026-03-25 | Current report | SEC filing | Apimeds Pharmaceuticals US, Inc. filed Form 8-K | Apimeds Pharmaceuticals US, Inc. filed Form 8-K covering items 5.02,5.03,8.01,9.01. |
| 2026-03-16 | Current report | SEC filing | Apimeds Pharmaceuticals US, Inc. filed Form 8-K | Apimeds Pharmaceuticals US, Inc. filed Form 8-K covering items 8.01. |
| 2026-02-17 | Current report | SEC filing | Apimeds Pharmaceuticals US, Inc. filed Form 8-K/A | Apimeds Pharmaceuticals US, Inc. filed Form 8-K/A covering items 2.01,9.01. |
| 2026-01-02 | Current report | SEC filing | Apimeds Pharmaceuticals US, Inc. filed Form 8-K | Apimeds Pharmaceuticals US, Inc. filed Form 8-K covering items 5.02. |
| 2025-12-10 | Current report | SEC filing | Apimeds Pharmaceuticals US, Inc. filed Form 8-K/A | Apimeds Pharmaceuticals US, Inc. filed Form 8-K/A covering items 1.01,3.03,5.03,9.01. |
| 2025-12-10 | Current report | SEC filing | Apimeds Pharmaceuticals US, Inc. filed Form 8-K | Apimeds Pharmaceuticals US, Inc. filed Form 8-K covering items 5.02. |
| 2025-12-02 | Current report | SEC filing | Apimeds Pharmaceuticals US, Inc. filed Form 8-K | Apimeds Pharmaceuticals US, Inc. filed Form 8-K covering items 1.01,2.01,2.03,3.02,5.01,5.02,5.03,7.01,9.01. |
| 2025-11-18 | Current report | SEC filing | Apimeds Pharmaceuticals US, Inc. filed Form 8-K | Apimeds Pharmaceuticals US, Inc. filed Form 8-K covering items 5.02,9.01. |
| 2025-10-16 | Current report | SEC filing | Apimeds Pharmaceuticals US, Inc. filed Form 8-K | Apimeds Pharmaceuticals US, Inc. filed Form 8-K covering items 5.03,9.01. |
| 2025-07-16 | Current report | SEC filing | Apimeds Pharmaceuticals US, Inc. filed Form 8-K | Apimeds Pharmaceuticals US, Inc. filed Form 8-K covering items 7.01,9.01. |
| 2025-06-05 | Current report | SEC filing | Apimeds Pharmaceuticals US, Inc. filed Form 8-K | Apimeds Pharmaceuticals US, Inc. filed Form 8-K covering items 5.02. |
| 2025-05-20 | Current report | SEC filing | Apimeds Pharmaceuticals US, Inc. filed Form 8-K | Apimeds Pharmaceuticals US, Inc. filed Form 8-K covering items 1.01,9.01. |
| 2025-05-12 | Current report | SEC filing | Apimeds Pharmaceuticals US, Inc. filed Form 8-K | Apimeds Pharmaceuticals US, Inc. filed Form 8-K covering items 1.01,3.02,7.01,9.01. |
| 2025-04-15 | Current report | SEC filing | Apimeds Pharmaceuticals US, Inc. filed Form 8-K | Apimeds Pharmaceuticals US, Inc. filed Form 8-K covering items 5.03,9.01. |